Yes. Making natural health products therapeutic products does not necessarily make them pharmaceuticals. In fact, the therapeutic products regime goes from pharmaceuticals and vaccines to medical devices. It is a broad category.
The real issues we're facing are regulatory. It has been identified from the time Vanessa's Law became law that we need to treat consumer health products differently from prescription drugs. The fact that we're spending this much time talking about labelling is one of the most obvious reasons for that, because you label a consumer product in such a way that consumers can use that product without any professional supervision.
Those kinds of issues that have developed over time—the cost recovery problem and the post-approval inspection issue, which is very real—are all things that emerged prior to the application of Vanessa's Law, and they'll still be here if Bill C-368 passes.